Hormone Treatment Linked to Increased Breast Cancer Risk, New Study Indicates

Hormone Treatment Linked to Increased Breast Cancer Risk, New Study Indicates

A recent study suggests that certain hormone therapies could heighten the risk of breast cancer in women, particularly for those under 55.

Understanding the Research Findings

Published in The Lancet Oncology, the study underscores an increased breast cancer risk associated with the use of estrogen combined with progesterone in women who have their uterus. Conversely, using estrogen without progesterone appears to reduce this risk.

Dr. Céline Gounder, a medical expert for CBS News, explained that the study assessed women under 55, categorizing them based on whether they still have their uterus, impacting the hormone treatment they received.

Hormone Therapy Differences Explained

The necessity for different hormone therapies is dictated by the presence or absence of a uterus. Women with a uterus require both estrogen and progesterone to prevent a rise in a different cancer type caused by estrogen alone, due to the thickening it causes in the uterine lining. In contrast, those without a uterus can safely use estrogen by itself.

The study distinguishes itself by highlighting that estrogen by itself can lower breast cancer risk, whereas combining it with progesterone might slightly elevate the risk.

Contextualizing the Results

This study offers a contemporary perspective on the evolving science of hormone therapy, moving beyond older research from the early 2000s, which primarily involved older women beginning hormone therapy years after menopause—a factor that drew critique over its design.

Today’s medical community generally views hormone therapy as a viable and effective option. The focus now is on the real-world scenario where women enter menopause in their 40s or 50s and begin treatment closer to that time.

Risks and Benefits of Hormone Therapy

Hormone therapy can entail risks such as heightened chances of heart disease, stroke, blood clots, and some cancers. However, it can also confer benefits like lowering cancer risk, preventing bone degradation, and alleviating menopause-related symptoms like hot flashes.

The study emphasizes the importance of the timing and type of hormone treatment, urging individuals to consult healthcare providers, taking into account personal and family medical history when deciding on the therapy.

Dr. Gounder advocates for personalized medical advice, noting that hormone therapy could be the most effective solution for many experiencing perimenopausal symptoms.

Further Insights

Sara Moniuszko, a health and lifestyle writer for CBS News, reports on this and other health stories, having a history of launching wellness-related content at previous publications.

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Posts